German group’s drugs chief warns EU and UK are dissuading investment as company prioritises US and China
Bayer shifts pharma focus away from ‘innovation unfriendly’ Europe
Recent Posts
- Starmer turns away from Trump’s Board of Peace as US-UK tensions mount
- The world’s economy — past, present and future
- Keir Starmer’s leadership under pressure from Angela Rayner and Andy Burnham
- How Trump turned mockery into a weapon of diplomacy
- Netflix switches to all-cash offer in battle for Warner Bros Discovery
